1-1 of 1
Myles B.C. Dillon
Close
Sort by
Journal Articles

HuLuc63 in Combination Regimens with Conventional and Targeted Therapies Has Additive and Synergistic Anti-Tumor Activity in Pre-Clinical Models of Myeloma.

Audie G. Rice, Myles B.C. Dillon, Anne M. Van Abbema, Daniel E.H. Afar
Journal: Blood
Blood (2007) 110 (11): 2517.
https://doi.org/10.1182/blood.V110.11.2517.2517
Published: 2007